Updated on 18 September 2026
Clinical Studies for Horizon Europe Cluster Health 2027
Head EU office at Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, Spain
About
IDIBAPS/Hospital Clínic Barcelona (HCB) is seeking collaboration opportunities in Horizon Europe Cluster Health 2027 proposals involving clinical studies. As a leading academic biomedical research institution and tertiary university hospital, IDIBAPS/HCB offers extensive expertise in the design, coordination and implementation of multicentre clinical trials, including advanced therapies, precision medicine, oncology and digital health interventions. The institution provides access to large patient cohorts, state-of-the-art clinical and translational research infrastructures, experienced Clinical Trials Unit (CTU) support, and strong capabilities in regulatory affairs, data management, biobanking and health outcomes research. We are interested in joining consortia as clinical trial partner, recruiting site, or WP leader for ambitious projects addressing the 2027 Cluster Health priorities.
Topic
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
- Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Medical-grade remote monitoring and digital endpoints for NCD and neurodegenerative clinical trials
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Kai Gand
Grants Manager at Corsano Health
The Hague, Netherlands
Project cooperation
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Ilias Nikolinakos
EU Grants and Funding Coordinator at Elpen Pharmaceutical Co. Inc.
Athens, Greece
Project cooperation
Smart Workflow Automation for Clinical Trial Management
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
George Nikolaidis
CEO at Ergobyte Informatics S.A.
Thessaloniki, Greece